Navigation Links
Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection

Vaccine trials conducted on Rotateq and Rotarix in more than 1, 30, 000 children offer promise in the prevention of childhood diarrhea. The vaccines have been found to be 98% and 85% effective respectively. // The dreadful disease accounts for 1/3rd of all hospital infections worldwide.

A vaccine had been developed for the disease during the 1990’s. This however, was withdrawn from the market owing to the possibility of a potential life-threatening condition, referred to as intussusception. This condition is characterized by intestinal folding, followed by intestinal blockage.

Almost all children suffer from rotavirus infection, at age 2 or 3. The most signs of infection include vomiting, fever, pain in the abdomen, watery diarrhea that can be fatal. Asymptomatic presentation can also be seen in a small proportion of the cases.

The incidence of rotavirus infection is estimated to be 1 in 38 in the UK. The incidence is even higher in the developing and underdeveloped countries. This can be attributed to poor sanitation and the lack of proper health care access.

Merck, a leading pharmaceutical company, has developed the vaccine, Rotateq. The vaccine can effectively manage five major strains of the rotavirus, believed to be associated with 90% of the infections. The study participants were divided into two groups; one group received the vaccine while the other group received a placebo. The study participants were closely monitored for the presence of adverse effects. A comparative revealed that there was no increased risk of side effects in the vaccine group.

Rotarix, an oral vaccine has been developed by GlaxoSmithKline and clinical trials were conducted to analyze the safety and efficacy of the formulation in over 63,000 infants. The study further documented a significant reduction in the hospital admissions related to rotavirus infection. No difference was seen in the complication rate as well.

"As vaccines become licensed and used in the US and Europe, we should expect to see a substantial reduction in winter hospitalizations, visits to doctors and clinics and parents' workdays lost to childhood diarrhea", said Dr Roger Glass and Dr Umesh Parashar, from the US Centers for Disease Control.

"Both vaccines will need to demonstrate their efficacy in the difficult settings of developing countries if we are to achieve our goal of maximally decreasing global deaths from diarrhea”, they concluded.


'"/>




Related medicine news :

1. Pakistani Quake Survivors Face Outbreak Of Diarrhea
2. Health Minister Inaugurates Institute for Diarrhea Diseases
3. A New Drug Promises To Be Very Effective In The Management Of Diarrhea
4. Two Die, 55 Afflicted With Gastroenteritis And Diarrhea
5. Mothers in African Study Undereducated on Diarrhea
6. GM Rice to Tackle Diarrhea
7. Vaccine to quit smoking?
8. First Vaccine Designed for Africa Cleared for Testing in Humans
9. Vaccine for Alzheimer’s diseas
10. Health Officials Recommend Flu Vaccine
11. Smallpox Vaccine May Help Fight Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... NY & Salt Lake City, UT (PRWEB) , ... February 05, ... ... Founder of Activz Whole-Food Nutrition , announced that the much-anticipated feature with author ... the New Really Cool Humans Amateur TV Network. , Each week, on his weekly ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... addition of micro-needling services in their Napa Valley office. The technique utilizes the ... Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a select ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: